Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Hiroshi Kitamura is a leading Japanese urologist whose research focuses on optimizing surgical and oncological outcomes for prostate and bladder cancers, with a particular emphasis on robot-assisted techniques. His major contributions center on large-scale, multicenter retrospective cohort studies (notably the MSUG94 group) that provide real-world evidence from Japan. Dr. Kitamura’s work has critically examined the role of pelvic lymphadenectomy, demonstrating that it may not improve biochemical recurrence-free survival in prostate cancer patients undergoing robot-assisted radical prostatectomy (RARP). He has also developed predictive nomograms for lymph node involvement and investigated prognostic factors such as lymphovascular invasion and positive surgical margin locations. With over 100 citations across his top papers, his 2020 clinical practice guidelines for bladder cancer, published by the Japanese Urological Association, have shaped national standards. His 2025 analysis of robot-assisted radical cystectomy using the National Clinical Database further underscores his commitment to evidence-based, minimally invasive surgery. Dr. Kitamura’s work is essential reading for urologists and researchers seeking to understand the evolving landscape of robotic urologic oncology in Japan.